Phase I data presented for cannabidivarin for treating epilepsy in patients with Rett syndrome Dec. 17, 2020
Abpro initiates phase II/III registrational studies of ABP-300 as treatment of COVID-19 Dec. 17, 2020
NP + GPC DNA vaccine candidate protects cynomolgus macaques from Crimean-Congo hemorrhagic fever Dec. 17, 2020
Cerecor initiates dosing in phase Ib study of CERC-007 in relapsed/refractory multiple myeloma Dec. 17, 2020